Endocrinology

Your Article Summary

See Latest Articles

Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone
Journal of Clinical Endocrinology and Metabolism, 11/09/09

Bechtold S et al. – During GH treatment, there was a significant increase and normalization of total bone and muscle CSA at final height. In accordance with an anabolic effect of GH, fat mass stabilized at the lower limit of healthy children. At final height, cortical and marrow CSA, relative to total bone CSA, were normalized in GH-treated patients.

• Longitudinal study
• Parameters of bone mineral density and geometry as well as muscle and fat cross-sectional area (CSA) in nondominant forearm recorded using peripheral quantitative computed tomography at yearly intervals until final height in 12 patients (seven females) receiving GH treatment
• Data at final height compared with 13 patients (nine females) with JIA not treated with GH

• Patients treated with GH for mean of 5.35 ± 0.7 y
• Correcting for height, total bone CSA (+0.89 ± 0.5 SD) and muscle CSA (+1.14 ± 0.6 SD) increased significantly and normalized at final height
• Compared with JIA patients without GH at final height, there was significantly higher muscle CSA and lower fat CSA in GH-treated patients
• In relation to total bone CSA, there was significantly more cortical and less marrow CSA in boys with GH treatment

Today in Metabolism and Growth...keeping you current

Receive free subspecialty "5-minute updates" via email

Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men
Journal of Clinical Endocrinology and Metabolism, 11/25/09

The Glucagon Test in the Diagnosis of Growth Hormone Deficiency in Children With Short Stature Younger than 6 Years
Journal of Clinical Endocrinology and Metabolism, 10/29/09

Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Journal of Hepatology, 11/04/09

See All of Metabolism and Growth